MicroRNA-30a-5p inhibits gallbladder cancer cell proliferation, migration and metastasis by targeting E2F7

[1]  Tonghua Liu,et al.  Asporin promotes pancreatic cancer cell invasion and migration by regulating the epithelial-to-mesenchymal transition (EMT) through both autocrine and paracrine mechanisms. , 2017, Cancer letters.

[2]  Claudio Stucchi,et al.  miR-875-5p counteracts epithelial-to-mesenchymal transition and enhances radiation response in prostate cancer through repression of the EGFR-ZEB1 axis. , 2017, Cancer letters.

[3]  R. Weinberg,et al.  Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas. , 2017, Cancer research.

[4]  Hongbing Shen,et al.  Downregulation of miR-218 contributes to epithelial–mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling , 2017, Oncogene.

[5]  W. Lu,et al.  MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway , 2017, Cell Death and Differentiation.

[6]  Hailing Lu,et al.  MicroRNA-30e reduces cell growth and enhances drug sensitivity to gefitinib in lung carcinoma , 2016, Oncotarget.

[7]  Jianwei Zhou,et al.  3,3'-Diindolylmethane induces anti-human gastric cancer cells by the miR-30e-ATG5 modulating autophagy. , 2016, Biochemical pharmacology.

[8]  H. Weng,et al.  miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinoma , 2016, Oncotarget.

[9]  P. Dong,et al.  Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression , 2016, Oncotarget.

[10]  B. Mittal,et al.  MicroRNA aberrations: An emerging field for gallbladder cancer management. , 2016, World journal of gastroenterology.

[11]  X. Chen,et al.  Heterochromatin protein HP1γ promotes colorectal cancer progression and is regulated by miR-30a. , 2015, Cancer research.

[12]  Long-Bang Chen,et al.  Correction: Non-small-cell lung cancer and miRNAs: novel biomarkers and promising tools for treatment. , 2015, Clinical science.

[13]  Lei Yu,et al.  MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma. , 2015, Journal of hepatology.

[14]  Yujie Liu,et al.  E2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a/16 promoter , 2015, Oncotarget.

[15]  Isabella Castiglioni,et al.  MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer , 2015, Theranostics.

[16]  Yan Li,et al.  MicroRNA-30d-5p inhibits tumour cell proliferation and motility by directly targeting CCNE2 in non-small cell lung cancer. , 2015, Cancer letters.

[17]  Y. Liu,et al.  Urinary microRNA-30a-5p is a potential biomarker for ovarian serous adenocarcinoma. , 2015, Oncology reports.

[18]  Y. Shang,et al.  miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2 , 2015, Cell Death and Disease.

[19]  Min Xu,et al.  MicroRNA-424 may function as a tumor suppressor in endometrial carcinoma cells by targeting E2F7. , 2015, Oncology reports.

[20]  W. Lu,et al.  SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway , 2015, Molecular Cancer.

[21]  S. Davis,et al.  miR30a inhibits LOX expression and anaplastic thyroid cancer progression. , 2015, Cancer research.

[22]  Maolan Li,et al.  Yes-associated protein 1 (YAP1) promotes human gallbladder tumor growth via activation of the AXL/MAPK pathway. , 2014, Cancer letters.

[23]  Jeffrey K. Mito,et al.  MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes. , 2014, The Journal of clinical investigation.

[24]  D. Spandidos,et al.  Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: prognostic value and prospective role in ovarian cancer therapeutics. , 2014, Cancer letters.

[25]  H. Weng,et al.  Clinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection: a retrospective and in vitro study , 2014, BMC Cancer.

[26]  W. Lu,et al.  Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway , 2014, Nature Genetics.

[27]  Hongda Wang,et al.  NEDD9 promotes lung cancer metastasis through epithelial–mesenchymal transition , 2014, International journal of cancer.

[28]  H. Weng,et al.  Oridonin induces apoptosis and cell cycle arrest of gallbladder cancer cells via the mitochondrial pathway , 2014, BMC Cancer.

[29]  T. Speed,et al.  A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression , 2014, Genes & development.

[30]  H. Weng,et al.  Evaluation of Two Inflammation-Based Prognostic Scores in Patients with Resectable Gallbladder Carcinoma , 2014, Annals of Surgical Oncology.

[31]  Jiwei Huang,et al.  Hypoxia‐induced downregulation of miR‐30c promotes epithelial‐mesenchymal transition in human renal cell carcinoma , 2013, Cancer science.

[32]  Shao-Hua Yang,et al.  PRDM1 is directly targeted by miR-30a-5p and modulates the Wnt/β-catenin pathway in a Dkk1-dependent manner during glioma growth. , 2013, Cancer letters.

[33]  A. Fatica,et al.  The microRNA-26a target E2F7 sustains cell proliferation and inhibits monocytic differentiation of acute myeloid leukemia cells , 2012, Cell Death and Disease.

[34]  J. Manfredi,et al.  E2F7, a novel target, is up-regulated by p53 and mediates DNA damage-dependent transcriptional repression. , 2012, Genes & development.

[35]  K. Pavelić,et al.  Metastasis: new perspectives on an old problem , 2011, Molecular Cancer.

[36]  S. Law,et al.  Characterization of a candidate tumor suppressor gene uroplakin 1A in esophageal squamous cell carcinoma. , 2010, Cancer research.

[37]  C. Croce,et al.  MicroRNAs in Cancer. , 2009, Annual review of medicine.

[38]  M. Hazar-Rethinam,et al.  E2F7 can regulate proliferation, differentiation, and apoptotic responses in human keratinocytes: implications for cutaneous squamous cell carcinoma formation. , 2009, Cancer research.

[39]  C. Croce,et al.  Specific microRNAs are downregulated in human thyroid anaplastic carcinomas , 2007, Oncogene.

[40]  K. Helin,et al.  E2F7, a novel E2F featuring DP‐independent repression of a subset of E2F‐regulated genes , 2003, The EMBO journal.